TARGeted therapy using intradermal injection of ETanercept to treat Discoid Lupus Erythematosus (TARGET-DLE)

Update Il y a 4 ans
Reference: EUCTR2015-001602-33

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the proportion of patients with active discoid lupus erythematosus (DLE) that achieves a clinical response as assessed using the modified Limited Score of Activity and Damage in DLE (SADDLE) tool (ie: defined as reduction in modified limited SADDLE score by 20% or more from baseline in the discoid lesion) at Week 12 following treatment with weekly intra-dermal injection of etanercept.


Inclusion criteria

  • Discoid lupus erythematosus

Links